Jefferies cuts Vistry price target to 560 (734) pence - 'hold' RBC cuts Vistry price target to 450 (500) pence - 'underperform' ...
(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for USD12 million. Syncona is a London-based investor in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback